Central anticholinergic syndrome with the antimalarial drug mefloquine.
about
Malaria Prevention, Mefloquine Neurotoxicity, Neuropsychiatric Illness, and Risk-Benefit Analysis in the Australian Defence ForceThe antimalarial potential of 4-quinolinecarbinolamines may be limited due to neurotoxicity and cross-resistance in mefloquine-resistant Plasmodium falciparum strainsSevere neuropsychiatric reaction in a deployed military member after prophylactic mefloquine.Complex Membrane Channel Blockade: A Unifying Hypothesis for the Prodromal and Acute Neuropsychiatric Sequelae Resulting from Exposure to the Antimalarial Drug Mefloquine.Ultrasound: An ode to perioperative complicated malaria.Neuropsychiatric manifestations after mefloquine therapy for Plasmodium falciparum malaria: comparing a retrospective and a prospective study.
P2860
Central anticholinergic syndrome with the antimalarial drug mefloquine.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Central anticholinergic syndrome with the antimalarial drug mefloquine.
@en
Central anticholinergic syndrome with the antimalarial drug mefloquine.
@nl
type
label
Central anticholinergic syndrome with the antimalarial drug mefloquine.
@en
Central anticholinergic syndrome with the antimalarial drug mefloquine.
@nl
prefLabel
Central anticholinergic syndrome with the antimalarial drug mefloquine.
@en
Central anticholinergic syndrome with the antimalarial drug mefloquine.
@nl
P1476
Central anticholinergic syndrome with the antimalarial drug mefloquine.
@en
P2093
P356
10.1056/NEJM199407073310120
P407
P577
1994-07-01T00:00:00Z